World Health Organization on Tuesday August 11, confirmed its intention to review and discuss the process for possible prequalification for Russia’s newly approved potential COVID-19 vaccine.
“We are in close contact with Russian health authorities and discussions are ongoing with respect to possible WHO prequalification of the vaccine, but again prequalification of any vaccine includes the rigorous review and assessment of all required safety and efficacy data,” WHO spokesman Tarik Jasarevic told a U.N. briefing in Geneva, referring to clinical trials.
Russia announced that the country would get involved in mass production of a vaccine, Sputnik Vaccine and market it all over the world. The vaccine will take two doses taken 21 days apart.
The Russian Healthcare Ministry has also given regulatory approval to the Coronavirus vaccine. It was developed by the Moscow-based Gamaleya Institute- Gamaleya National Centre of Epidemiology and Microbiology.
A total of 28 of more than 150 potential vaccines are currently being actively tested with six at Phase 3, the final stage where candidate drugs are tested on large groups of people as per WHO authorization.
Russia’s vaccine is in its first stage of being tested; Phase 1.
However, Russia’s intentions to market the vaccine have drawn a lot of concern and interest of most critiques.
Dr. Anthony Fauci, the Director of the U.S. National Institute of Allergy and Infectious Diseases said, “concocting a COVID-19 vaccine is not the same as proving a vaccine that is safe and effective.”